Although bioprosthetic surgical aortic valve replacement (bio-SAVR) is generally well-tolerated, patients are thought to be at increased risk of thromboembolism for up to 90 days following bio-SAVR, supporting the current guidelines recommending the use of an anticoagulation regimen for at least the first 3 months following bio-SAVR. This video reviews the current guidelines, literature, and controversy regarding the topic of anticoagulation in bio-SAVR patients.
First-of-its-kind study examines the impact of ‘sham feeding’ on patient recovery
CHICAGO (September 10, 2021) — Chewing gum after heart surgery may kickstart the digestive tract, helping patients feel better and potentially be discharged sooner than those who don't use this generally safe and simple intervention, according to research presented today at the 18th Annual Perioperative and Critical Care Conference from The Society of Thoracic Surgeons.
New gender-directed strategies are needed to treat acute aortic dissection, experts say
CHICAGO (June 2, 2021) — Women who experience acute aortic dissection—a spontaneous and catastrophic tear in one of the body’s main arteries—not only are older and have more advanced disease than men when they seek medical care, but they also are more likely to die, according to research published online today in The Annals of Thoracic Surgery.
Joseph E. Bavaria, MD, and an expert panel engage in a lively and robust debate on takeaways from three recent and very prominent adult cardiac surgery manuscripts.
Right ventricular (RV) failure occurs when the right ventricle does not maintain enough blood flow through the pulmonary circulation to achieve adequate left ventricular filling. This video reviews the pathophysiology, diagnosis, and management of RV failure after cardiac surgery.
Presenters:
Nathalie Roy, MD
Harvard University, Boston Children’s Hospital
Hitoshi Hirose MD, PhD
Thomas Jefferson University
An expert panel debate the merits of surgical versus transcatheter treatments and review challenging mitral valve cases such as degenerative mitral regurgitation, mitral annular calcification, functional mitral valve regurgitation, and failed bioprosthetic mitral valve.
Why Is This Even an Issue? by Daniel T. Engelman, MD, and Now What Do I Do? by Michael C. Grant, MD, MSE – explore the role of cardiac surgery as a contributor to the opioid epidemic.
A panel of cardiothoracic surgeons and cardiologists review challenging cases of aortic stenosis and debate the merits of SAVR vs. TAVR as the preferred treatment.
